Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
News + Filings
Transactions
Holdings
All
13F
13D/G
Other
Lung Therapeutics, Inc.
Create:
Alert
All
|
News
|
Filings
Date Filed
Type
Description
02/14/2023
SC 13G/A
Lung Therapeutics, Inc. reports a 2.1% stake in TFF Pharmaceuticals, Inc.
04/04/2022
D
Form D - Notice of Exempt Offering of Securities:
02/14/2022
SC 13G/A
Lung Therapeutics, Inc. reports a 8.8% stake in TFF Pharmaceuticals, Inc.
03/30/2021
4
Form 4 - Statement of changes in beneficial ownership of securities:
02/03/2021
SC 13G/A
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
12/08/2020
4
Lung Therapeutics, Inc. (10% Owner) has filed a Form 4 on TFF Pharmaceuticals, Inc.
Txns:
Sold 500,000 shares @ $13.85, valued at $6.9M
Sold 300,000 shares @ $13.86, valued at $4.2M
Sold 250,000 shares @ $13.86, valued at $3.5M
02/03/2020
SC 13G
Lung Therapeutics, Inc. reports a 21.7% stake in TFF Pharmaceuticals, Inc.
10/31/2019
D/A
Form D/A - Notice of Exempt Offering of Securities: [Amend]
10/24/2019
3
Form 3 - Initial statement of beneficial ownership of securities:
05/24/2019
D
Form D - Notice of Exempt Offering of Securities:
06/18/2018
D
Form D - Notice of Exempt Offering of Securities:
05/19/2017
D/A
Form D/A - Notice of Exempt Offering of Securities [Amend]
02/24/2017
D/A
Form D/A - Notice of Exempt Offering of Securities [Amend]
03/08/2016
D
Form D - Notice of Exempt Offering of Securities
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy